Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Michelangelo Marasco
Observed names:
M. Marasco,
Marasco, Michelangelo
Institutions:
Università Cattolica del Sacro Cuore,
Memorial Sloan Kettering Cancer Center
Observed institutions:
Università Cattolica del Sacro Cuore,
Leibniz University Hannover,
Memorial Sloan Kettering Cancer Center,
Agostino Gemelli University Polyclinic
ORCID:
0000-0001-7082-9824
Observed ORCID:
0000-0001-7082-9824
OpenAlex ID:
A5041526574
Molecular mechanism of SHP2 activation by PD-1 stimulation
2020
·
M. Marasco
, A. Berteotti
, et al.
·
Science Advances
·
295
PDF
Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
2022
·
Rona Yaeger
, Riccardo Mezzadra
, et al.
·
Cancer Discovery
·
160
PDF
Anatomic position determines oncogenic specificity in melanoma
2022
·
Joshua M. Weiss
, Miranda V. Hunter
, et al.
·
Nature
·
107
PDF
Specificity and regulation of phosphotyrosine signaling through SH2 domains
2020
·
Michelangelo Marasco
, Teresa Carlomagno
·
Journal of Structural Biology X
·
41
PDF
Phosphotyrosine couples peptide binding and SHP2 activation via a dynamic allosteric network
2021
·
Michelangelo Marasco
, John Kirkpatrick
, et al.
·
Computational and Structural Biotechnology Journal
·
40
PDF
Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations
2025
·
Michelangelo Marasco
, Dinesh Kumar
, et al.
·
Cancer Discovery
·
21
Resistance is futile with fourth-generation EGFR inhibitors
2022
·
Michelangelo Marasco
, Sandra Misale
·
Nature Cancer
·
12
Phosphopeptide binding to the N-SH2 domain of tyrosine phosphatase SHP2 correlates with the unzipping of its central β-sheet
2024
·
Michelangelo Marasco
, John Kirkpatrick
, et al.
·
Computational and Structural Biotechnology Journal
·
9
PDF
Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma
2024
·
Michelangelo Marasco
, Dinesh Kumar
, et al.
·
Cell Reports Medicine
·
7
Experiment-guided molecular simulations define a heterogeneous structural ensemble for the PTPN11 tandem SH2 domains
2023
·
Michelangelo Marasco
, John Kirkpatrick
, et al.
·
Chemical Science
·
6
PDF
Recruitment of phospholipase Cγ1 to the non-structural membrane protein pK15 of Kaposi Sarcoma-associated herpesvirus promotes its Src-dependent phosphorylation
2021
·
Naira Samarina
, George Ssebyatika
, et al.
·
PLoS Pathogens
·
6
PDF
The Far Side of Resistance to RAS Inhibitors
2024
·
Michelangelo Marasco
, Sandra Misale
·
Cancer Discovery
·
5
Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma
2025
·
M. Marasco
, D. Kumar
, et al.
·
EJC Skin Cancer
·
3
PDF
1H, 13C, 15N chemical shift assignments of SHP2 SH2 domains in complex with PD-1 immune-tyrosine motifs
2020
·
Michelangelo Marasco
, John P. Kirkpatrick
, et al.
·
Biomolecular NMR Assignments
·
3
PDF
NMR Methods to Study the Dynamics of SH2 Domain–Phosphopeptide Complexes
2023
·
Michelangelo Marasco
, John P. Kirkpatrick
, et al.
·
Methods in molecular biology
·
1
Methods for Structure Determination of SH2 Domain–Phosphopeptide Complexes by NMR
2023
·
Vittoria Nanna
, Michelangelo Marasco
, et al.
·
Methods in molecular biology
·
1
Molecular characterization of acquired resistance to KRAS G12C inhibition in gastrointestinal cancers
2022
·
Sandra Misale
, Rona Yaeger
, et al.
·
Research Square
·
1
PDF
Supplementary Table 1 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
2025
·
Rona Yaeger
, Riccardo Mezzadra
, et al.
Supplementary Figure 4 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
2025
·
Rona Yaeger
, Riccardo Mezzadra
, et al.
PDF
Supplementary Figure 1 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
2025
·
Rona Yaeger
, Riccardo Mezzadra
, et al.
PDF
Supplementary Table 2 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
2025
·
Rona Yaeger
, Riccardo Mezzadra
, et al.
Supplementary Figure 3 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
2025
·
Rona Yaeger
, Riccardo Mezzadra
, et al.
PDF
Supplementary Figure 5 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
2025
·
Rona Yaeger
, Riccardo Mezzadra
, et al.
PDF
Supplementary Figure 2 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
2025
·
Rona Yaeger
, Riccardo Mezzadra
, et al.
PDF
Supplementary Figure 6 from Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer
2025
·
Rona Yaeger
, Riccardo Mezzadra
, et al.
PDF
Show more works
View as search
Works count:
87
Citation count:
718
H-index:
8
I10-index:
7
Year
Topic
Type